Vivistim Registry for Paired VNS Therapy (GRASP)

The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to provide real-world usage and outcomes data on the Vivistim System. The patient outcome Registry will collect follow-up data on Vivistim implanted patients treated with Paired VNS Therapy after FDA approval.

Information about participants medical history, implant and quality of life will be gathered on patients who consider implant of the Vivistim System. Data will be collected at baseline, 3, 6, and 12 months after implantation, and then yearly thereafter for up to 3 years post-implant. Patients who decide not to have the Vivistim System implanted can continue to have data collected for comparison purposes.

The Vivistim Registry for Paired VNS Therapy (GRASP) is listed on ClinicalTrials.gov NCT05301140 and is currently enrolling. 

Find more information about Vivistim on our clinical resources page or at Vivistim.com